mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for FSCN1
Gene summary
Basic gene Info.Gene symbolFSCN1
Gene namefascin actin-bundling protein 1
SynonymsFAN1|HSN|SNL|p55
CytomapUCSC genome browser: 7p22
Type of geneprotein-coding
RefGenesNM_003088.3,
Description55 kDa actin-bundling proteinfascinfascin homolog 1, actin-bundling proteinsinged-like (fascin homolog, sea urchin)
Modification date20141207
dbXrefs MIM : 602689
HGNC : HGNC
Ensembl : ENSG00000075618
HPRD : 04068
Vega : OTTHUMG00000090599
ProteinUniProt: Q16658
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_FSCN1
BioGPS: 6624
PathwayNCI Pathway Interaction Database: FSCN1
KEGG: FSCN1
REACTOME: FSCN1
Pathway Commons: FSCN1
ContextiHOP: FSCN1
ligand binding site mutation search in PubMed: FSCN1
UCL Cancer Institute: FSCN1
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0030036actin cytoskeleton organization9571235
GO:0048870cell motility9571235
GO:0051017actin filament bundle assembly20393565


Top
Ligand binding site mutations for FSCN1
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
R383R383CCOAD1
F452F451LLUAD1
F181A180VSKCM1
G352K353NSKCM1
K304T302ISKCM1
V33A35VSTAD1
D342R341HSTAD1
R118R118HSTAD1
R343,I345R344HUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for FSCN1
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
R383R383C-1.3177033
G352K353N-1.2449042
R118R118H-1.1720131
R343R344H-1.1714155
I345R344H-1.1714155
D342R341H-0.99699226
K304T302I-0.90455963
F452F451L-0.76853555
F181A180V-0.73869835
V33A35V-0.47409559
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for FSCN1 from PDB

Top
Differential gene expression and gene-gene network for FSCN1
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of FSCN1 and the right PPI network was created from samples without mutations in the LBS of FSCN1. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for FSCN1
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for FSCN1
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of FSCN1 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
GOLGLYCEROL3p53AD342 F452
GOLGLYCEROL3p53BD342 R343 I345 F452
12PDODECAETHYLENE GLYCOL3p53AF181
GOLGLYCEROL3p53AK304 G352
GOLGLYCEROL3p53AR383
GOLGLYCEROL3p53BR383
GOLGLYCEROL3p53BV33
GOLGLYCEROL3p53AV33 R118


Top
Conservation information for LBS of FSCN1
Multiple alignments for Q16658 in multiple species
LBSAA sequence# speciesSpecies
A349RITLRASNGKF3Homo sapiens, Mus musculus, Rattus norvegicus
C19FGLISCGNKYL2Mus musculus, Rattus norvegicus
C19FGLINCGNKYL1Homo sapiens
D117FGGTEDRLSCF3Homo sapiens, Mus musculus, Rattus norvegicus
D337ASCYFDIEWRD1Homo sapiens
D337ASCYFDIEWCD1Mus musculus
D337ASCYFDIEWCE1Rattus norvegicus
D342DIEWRDRRITL1Homo sapiens
D342DIEWCDRRITL1Mus musculus
D342DIEWCERRITL1Rattus norvegicus
D98VVAHDDGRWSL2Mus musculus, Rattus norvegicus
D98IVAHDDGRWSL1Homo sapiens
F181LITLAFQDQRY3Homo sapiens, Mus musculus, Rattus norvegicus
F418VFQLEFNDGAY3Homo sapiens, Mus musculus, Rattus norvegicus
F452TPVDFFLEFCD2Mus musculus, Rattus norvegicus
F452TPVDFFFEFCD1Homo sapiens
F453PVDFFLEFCDY2Mus musculus, Rattus norvegicus
F453PVDFFFEFCDY1Homo sapiens
G352LRASNGKFVTA2Mus musculus, Rattus norvegicus
G352LRASNGKFVTS1Homo sapiens
G421LEFNDGAYNIK3Homo sapiens, Mus musculus, Rattus norvegicus
I17IQFGLISCGNK2Mus musculus, Rattus norvegicus
I17IQFGLINCGNK1Homo sapiens
I345WRDRRITLRAS1Homo sapiens
I345WCDRRITLRAS1Mus musculus
I345WCERRITLRAS1Rattus norvegicus
I381FLMKLINRPII3Homo sapiens, Mus musculus, Rattus norvegicus
K131VSPAEKWSVHI3Homo sapiens, Mus musculus, Rattus norvegicus
K304DRDTRKCAFRT2Mus musculus, Rattus norvegicus
K304DRDTKKCAFRT1Homo sapiens
K32EAFGFKVNASA3Homo sapiens, Mus musculus, Rattus norvegicus
L119GTEDRLSCFAQ3Homo sapiens, Mus musculus, Rattus norvegicus
L380LFLMKLINRPI3Homo sapiens, Mus musculus, Rattus norvegicus
L416YDVFQLEFNDG3Homo sapiens, Mus musculus, Rattus norvegicus
M378SELFLMKLINR3Homo sapiens, Mus musculus, Rattus norvegicus
N18QFGLISCGNKY2Mus musculus, Rattus norvegicus
N18QFGLINCGNKY1Homo sapiens
N382LMKLINRPIIV3Homo sapiens, Mus musculus, Rattus norvegicus
P128AQSVSPAEKWS2Mus musculus, Rattus norvegicus
P128AQTVSPAEKWS1Homo sapiens
P384KLINRPIIVFR3Homo sapiens, Mus musculus, Rattus norvegicus
Q184LAFQDQRYSVQ3Homo sapiens, Mus musculus, Rattus norvegicus
R100AHDDGRWSLQS3Homo sapiens, Mus musculus, Rattus norvegicus
R118GGTEDRLSCFA3Homo sapiens, Mus musculus, Rattus norvegicus
R185AFQDQRYSVQT3Homo sapiens, Mus musculus, Rattus norvegicus
R343IEWRDRRITLR1Homo sapiens
R343IEWCDRRITLR1Mus musculus
R343IEWCERRITLR1Rattus norvegicus
R348RRITLRASNGK3Homo sapiens, Mus musculus, Rattus norvegicus
R383MKLINRPIIVF3Homo sapiens, Mus musculus, Rattus norvegicus
S133PAEKWSVHIAM3Homo sapiens, Mus musculus, Rattus norvegicus
S350ITLRASNGKFV3Homo sapiens, Mus musculus, Rattus norvegicus
V33AFGFKVNASAS3Homo sapiens, Mus musculus, Rattus norvegicus
V78DKDGNVTCERE3Homo sapiens, Mus musculus, Rattus norvegicus
Y186FQDQRYSVQTS2Mus musculus, Rattus norvegicus
Y186FQDQRYSVQTA1Homo sapiens
Y423FNDGAYNIKDS3Homo sapiens, Mus musculus, Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas